Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Hyperglycemia

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Hyperglycemia in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Hyperglycemia: Abnormally high BLOOD GLUCOSE level.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Yamauchi, T1
Waki, H1
Kamon, J1
Murakami, K1
Motojima, K1
Komeda, K1
Miki, H1
Kubota, N1
Terauchi, Y1
Tsuchida, A1
Tsuboyama-Kasaoka, N1
Yamauchi, N1
Ide, T1
Hori, W1
Kato, S1
Fukayama, M1
Akanuma, Y1
Ezaki, O1
Itai, A1
Nagai, R1
Kimura, S1
Tobe, K1
Kagechika, H1
Shudo, K1
Kadowaki, T1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Hyperglycemia

ArticleYear
Inhibition of RXR and PPARgamma ameliorates diet-induced obesity and type 2 diabetes.
    The Journal of clinical investigation, 2001, Volume: 108, Issue:7

    Topics: 3T3 Cells; Adipose Tissue; Animals; Benzhydryl Compounds; Benzoates; Biphenyl Compounds; Diabetes Me

2001